LOGIN  |  REGISTER
Cue Biopharma

LevelJump Healthcare: Integration of Sage Intacct, Grant of Restricted Share Units, & Update on Private Placement

January 10, 2024 | Last Trade: C$0.05 0.00 0.00

Toronto, Ontario--(Newsfile Corp. - January 10, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce the seamless integration of Sage Intacct across its subsidiaries.

This advanced solution optimizes the accounting and HR processes and should result in cost savings and efficiencies for JUMP as the Company acquires more locations and continues to grow operations. The integration of Sage is planned to go live this quarter.

"LevelJump remains committed to innovation and continuous improvement, and the integration of Sage Intacct reflects our dedication to providing operational excellence. We look forward to the positive impact this collaboration will have on our financial capabilities and overall business success." Said Rob Landau, CFO.

Grant of Restricted Share Units ("RSUs")

The Company is also pleased to announce that it has issued 60,000 common shares pursuant to the redemption of 60,000 Restricted Share Units ("RSUs") originally granted to an employee on January 1, 2021.

The deemed issue price of these shares is 40,000 at $0.12 per share and 20,000 at $0.11 per share. The issue price was determined based on the date the RSUs vested.

Update on Non-Brokered Private Placement

The Company also wishes to announce that, following receipt of Exchange approval, and further to its news releases dated September 14, 2023, and October 28, 2023, there have been no further closings under the Company's previous private placement.

Information on a new preferred share offering can be found in the Company's press release dated November 28, 2023.

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer

Caitlin-Robyn Densmore
Investor Relations Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
(437) 214-1568

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

Astria Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB